Cargando…
Update meta-analysis on the efficacy and safety issues of fexofenadine
BACKGROUND: Fexofenadine emerged as one of the most representative second generation histamine H1 antagonist drugs since the 1990s, with an outstanding efficacy and appreciable safety for the treatment of allergic patients. While allergic rhino-conjunctivitis represents the most frequent atopic dise...
Autores principales: | Gómez, René Maximiliano, Moreno, Pablo, Compalati, Enrico, Canonica, Giorgio Walter, Ansotegui Zubeldia, Ignacio Javier |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
World Allergy Organization
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10401337/ https://www.ncbi.nlm.nih.gov/pubmed/37546236 http://dx.doi.org/10.1016/j.waojou.2023.100795 |
Ejemplares similares
-
Insights into urticaria in pediatric and adult populations and its management with fexofenadine hydrochloride
por: Ansotegui, Ignacio J., et al.
Publicado: (2022) -
Correction to: Insights into urticaria in pediatric and adult populations and its management with fexofenadine hydrochloride
por: Ansotegui, Ignacio J., et al.
Publicado: (2022) -
Sublingual Immunotherapy: Clinical Indications in the WAO-SLIT Position Paper
por: Passalacqua, Giovanni, et al.
Publicado: (2010) -
Fexofenadine-Induced Urticaria
por: Lee, Sang Woo, et al.
Publicado: (2011) -
Fexofenadine: review of safety, efficacy and unmet needs in children with allergic rhinitis
por: Meltzer, Eli O., et al.
Publicado: (2021)